Olaparib trials for BRCA2 Mutation

All Olaparib trials · All BRCA2 Mutation trials

Phase breakdown

Recruiting trials studying Olaparib for BRCA2 Mutation

• Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer
  NCT06201234 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 36 locations
• Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
  NCT05485766 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
  NCT06488378 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Common questions

How many trials study Olaparib for BRCA2 Mutation?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.